Nitrosamines Analysis in Pharmaceuticals - Consumables workflow ordering guide
Příručky | 2021 | Agilent TechnologiesInstrumentace
GC kolony, Spotřební materiál
ZaměřeníFarmaceutická analýza
VýrobceAgilent Technologies
Klíčová slovanitrosamine, nitrosamines, ndma, ndea, mylist, favorite, neipa, ndipa, drug, ppm, items, click, inlet, replacement, supplies, your, ndba, gas, parameters, collar, temperature, purifier, standards, quadrupole, lod, nitrosodiethylamine, loq, mode, impurities, product, substance, tightening, nitrosodimethylamine, products, find, column, nut, liners, caps, fill, self, download, list, header, filters, split, impurity, all, selector, vials
Podobná PDF
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|PříručkyPrezentace
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Klíčová slova
back, backndma, ndmaneipa, neipafda, fdandipa, ndipandea, ndeandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanbest, bestquant, quantdichloromethan
Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation
2020|Agilent Technologies|Aplikace
Application Note Pharma & Biopharma Analysis of Five Nitrosamine Impurities in Drug Products and Drug Substances Using Agilent GC/MS/MS Instrumentation Authors Soma Dasgupta, Lalith Hansoge, Vivek Dhyani, Samir Vyas, and Melissa Churley Agilent Technologies, Inc. Abstract This application note highlights…
Klíčová slova
relative, relativeresponses, responsesndba, ndbaneipa, neipandipa, ndipandma, ndmandea, ndeaotr, otrstd, stdfda, fdacounts, countsconcentration, concentrationacquisition, acquisitiondrug, drugimpurities
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Technické články
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapmass, massaquisition, aquisitionexactive, exactivesource, sourceloop, loopkpa
Overcoming the challenges of nitrosamine impurities in drugs
2020|Thermo Fisher Scientific|Ostatní
CASE STUDY 73263 Overcoming the challenges of nitrosamine impurities in drugs What pharmaceutical QA/QC laboratories need to know: Advanced GC-MS capabilities for cGMP nitrosamine testing Why we need to analyze nitrosamine impurities in drugs Unacceptable levels of nitrosamine impurities were…
Klíčová slova
min, minndma, ndmandea, ndeanitrosamine, nitrosamineneipa, neipatime, timetemperature, temperatureimpurities, impuritiesorbitrap, orbitrapaquisition, aquisitionmass, massexactive, exactivesource, sourceloop, loopkpa